578 related articles for article (PubMed ID: 33630927)
1. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
[TBL] [Abstract][Full Text] [Related]
2. An overview on the seven pathogenic human coronaviruses.
Kesheh MM; Hosseini P; Soltani S; Zandi M
Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
[TBL] [Abstract][Full Text] [Related]
3. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
4. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
[TBL] [Abstract][Full Text] [Related]
5. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
Qin S; Xia X; Shi X; Ji X; Ma F; Chen L
Bioinformatics; 2021 Jan; 36(21):5133-5138. PubMed ID: 32805023
[TBL] [Abstract][Full Text] [Related]
7. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.
Gerna G; Campanini G; Rovida F; Percivalle E; Sarasini A; Marchi A; Baldanti F
J Med Virol; 2006 Jul; 78(7):938-49. PubMed ID: 16721849
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
[TBL] [Abstract][Full Text] [Related]
9. Coronavirus HKU1 and other coronavirus infections in Hong Kong.
Lau SK; Woo PC; Yip CC; Tse H; Tsoi HW; Cheng VC; Lee P; Tang BS; Cheung CH; Lee RA; So LY; Lau YL; Chan KH; Yuen KY
J Clin Microbiol; 2006 Jun; 44(6):2063-71. PubMed ID: 16757599
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the post-fusion core of the Human coronavirus 229E spike protein at 1.86 Å resolution.
Yan L; Meng B; Xiang J; Wilson IA; Yang B
Acta Crystallogr D Struct Biol; 2018 Sep; 74(Pt 9):841-851. PubMed ID: 30198895
[TBL] [Abstract][Full Text] [Related]
11. The dominance of human coronavirus OC43 and NL63 infections in infants.
Dijkman R; Jebbink MF; Gaunt E; Rossen JW; Templeton KE; Kuijpers TW; van der Hoek L
J Clin Virol; 2012 Feb; 53(2):135-9. PubMed ID: 22188723
[TBL] [Abstract][Full Text] [Related]
12. Improved Culture Methods for Human Coronaviruses HCoV-OC43, HCoV-229E, and HCoV-NL63.
Fausto A; Otter CJ; Bracci N; Weiss SR
Curr Protoc; 2023 Oct; 3(10):e914. PubMed ID: 37882768
[TBL] [Abstract][Full Text] [Related]
13. [Coronaviruses as the cause of respiratory infections].
Corman VM; Lienau J; Witzenrath M
Internist (Berl); 2019 Nov; 60(11):1136-1145. PubMed ID: 31455974
[TBL] [Abstract][Full Text] [Related]
14. [SARS, MERS and coronavirus infections].
Kawana A
Nihon Rinsho; 2016 Dec; 74(12):1967-1972. PubMed ID: 30550651
[TBL] [Abstract][Full Text] [Related]
15. Sero-epidemiology of human coronaviruses in three rural communities in Ghana.
Owusu M; Sylverken AA; El-Duah P; Acheampong G; Mutocheluh M; Adu-Sarkodie Y
Pan Afr Med J; 2021; 38():244. PubMed ID: 34104292
[TBL] [Abstract][Full Text] [Related]
16. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.
Schneider WM; Luna JM; Hoffmann HH; Sánchez-Rivera FJ; Leal AA; Ashbrook AW; Le Pen J; Ricardo-Lax I; Michailidis E; Peace A; Stenzel AF; Lowe SW; MacDonald MR; Rice CM; Poirier JT
Cell; 2021 Jan; 184(1):120-132.e14. PubMed ID: 33382968
[TBL] [Abstract][Full Text] [Related]
17. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM
Front Immunol; 2022; 13():954093. PubMed ID: 36159791
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of Bat Coronaviruses in Kenya Identifies Relatives of Human Coronaviruses NL63 and 229E and Their Recombination History.
Tao Y; Shi M; Chommanard C; Queen K; Zhang J; Markotter W; Kuzmin IV; Holmes EC; Tong S
J Virol; 2017 Mar; 91(5):. PubMed ID: 28077633
[TBL] [Abstract][Full Text] [Related]
19. Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses.
Otter CJ; Fausto A; Tan LH; Khosla AS; Cohen NA; Weiss SR
Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2218083120. PubMed ID: 37023127
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication.
Yan B; Chu H; Yang D; Sze KH; Lai PM; Yuan S; Shuai H; Wang Y; Kao RY; Chan JF; Yuen KY
Viruses; 2019 Jan; 11(1):. PubMed ID: 30654597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
